CoChat

Genetic variation in cyclooxygenase 1: Effects on response to aspirin

Halushka, Marc K., Walker, Linda P., Halushka, Perry V. · 2003 · Clinical Pharmacology & Therapeutics
Cited by 266

The DOI matches its Crossref record.

Abstract

Background: A critical clinical application of the Human Genome Project is to identify functional variation in genes related to disease or responses to xenobiotics. This study moved toward that goal by combining polymorphism detection with functional assays for the therapeutic target gene cyclooxygenase 1 (COX‐1). Cyclooxygenase 1 (prostaglandin endoperoxide G/H synthase [PTGS1]) catalyzes the metabolism of arachidonic acid to prostaglandin H 2, which is subsequently metabolized to thromboxane A 2. Methods: Thirty‐eight healthy participants were enrolled in this study to correlate functional and genetic variation of cyclooxygenase 1. Arachidonic acid, with and without aspirin (acetylsalicylic acid) and ethanol pretreatment, was used to stimulate the formation of prostaglandin H 2, measured as prostaglandin F 2α (PGF 2α), in human platelets. The cyclooxygenase 1 complementary deoxyribonucleic acid coding sequence and genomic deoxyribonucleic acid upstream from the cyclooxygenase 1 transcription start site (2.9 kilobases) were sequenced in 38 individuals, with 9 single‐nucleotide polymorphisms identified. Results: Two single‐nucleotide polymorphisms, A‐842G and C50T, were in complete linkage disequilibrium. Participants who were heterozygous for the A‐842G/C50T haplotype showed significantly (P = .01) greater inhibition of prostaglandin H 2 formation by acetylsalicylic acid (30 μmol/L) compared with common allele homozygotes. Conclusions: The discovery of a functional single‐nucleotide polymorphism in the cyclooxygenase 1 locus may ultimately improve the safe and effective use of acetylsalicylic acid by better tailoring of dosage with an individual's genetic variation. Clinical Pharmacology & Therapeutics (2003) 73, 122–130; doi: 10.1067/mcp.2003.1

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1067/mcp.2003.1

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 266

Metadata

Authors
Halushka, M. K., Walker, L. P., & Halushka, P. V.
Venue
Clinical Pharmacology & Therapeutics
Publisher
Wiley
Published
2003-01
Volume
73
Issue
1
Pages
122-130
ISSN
  • 0009-9236 (ISSN-L)
  • 1532-6535
OpenAlex
W2108925673
Cited by
266
References
0
FWCI
16.03
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Genetic variation in cyclooxygenase 1: Effects on response to aspirin. https://app.cochat.ai/papers/10.1067/mcp.2003.1
The paper
Halushka, M. K., Walker, L. P., & Halushka, P. V. (2003). Genetic variation in cyclooxygenase 1: Effects on response to aspirin. Clinical Pharmacology & Therapeutics. https://doi.org/10.1067/mcp.2003.1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.